BB&T Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

BB&T Securities’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$406K	Sell	5,317 -358	-6%	-$29.8K	﹤0.01%	1184
2019 Q2	$497K	Sell	5,675 -159	-3%	-$13.6K	﹤0.01%	1103
2019 Q1	$528K	Sell	5,834 -2,782	-32%	-$237K	0.01%	1050
2018 Q4	$618K	Sell	8,616 -2,354	-21%	-$190K	0.01%	903
2018 Q3	$1.05M	Sell	10,970 -563	-5%	-$54.6K	0.01%	809
2018 Q2	$1.1M	Buy	11,533 +635	+6%	+$58.4K	0.01%	779
2018 Q1	$956K	Sell	10,898 -22,521	-67%	-$2.06M	0.01%	796
2017 Q4	$2.84M	Buy	33,419 +3	+0%	+$251	0.04%	454
2017 Q3	$2.89M	Sell	33,416 -1,054	-3%	-$84.5K	0.04%	442
2017 Q2	$2.66M	Sell	34,470 -2,115	-6%	-$150K	0.04%	450
2017 Q1	$2.54M	Buy	36,585 +5,209	+17%	+$350K	0.03%	413
2016 Q4	$2.08M	Hold	31,376	–	–	0.03%	434
2016 Q3	$2.08M	Sell	31,376 -15,775	-33%	-$976K	0.03%	426
2016 Q2	$2.55M	Buy	+47,151	New	+$2.58M	0.04%	372
2016 Q1	–	Sell	-3,366	Closed	-$236K	–	1243
2015 Q4	$236K	Buy	+3,366	New	+$230K	﹤0.01%	1014

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

BB&T Securities's XBI Position: Q3 2019 in Review

BB&T Securities reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 6.3% in Q3 2019, selling an estimated $29.8K and leaving 5,317 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #1184.

BB&T Securities first reported a position in XBI in Q4 2015 and has held it in 15 quarters since. The position peaked at $2.89M in Q3 2017. 406 funds tracked by Wall St. Rank hold XBI as of Q3 2019.

BB&T Securities held 5,317 shares of State Street SPDR S&P Biotech ETF worth $406K as of Q3 2019.
BB&T Securities sold 358 State Street SPDR S&P Biotech ETF shares in Q3 2019, an estimated $29.8K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1184 holding.
BB&T Securities first reported a position in State Street SPDR S&P Biotech ETF in Q4 2015 and has held it in 15 quarters since.
BB&T Securities's State Street SPDR S&P Biotech ETF position peaked at $2.89M in Q3 2017.
406 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.